Copyright
©The Author(s) 2019.
World J Gastrointest Endosc. Oct 16, 2019; 11(10): 504-514
Published online Oct 16, 2019. doi: 10.4253/wjge.v11.i10.504
Published online Oct 16, 2019. doi: 10.4253/wjge.v11.i10.504
Table 3 Comparison between inpatient mortality, mean hospitalization cost of care, and mean length of stay between end-stage renal disease and angiodysplasia associated-gastrointestinal bleeding, and end-stage renal disease hospitalizations, 2009-2014
| Mortality | Total charges | Length of stay | ||||
| Odds ratio (95%CI) | P value | Difference (95%CI) | P value | Difference (95%CI) | P value | |
| Angiodysplasia | 0.67 (0.58, 0.78) | < 0.0001 | $17761 ($12550, $22973) | < 0.0001 | 1.86 (1.40, 2.32) | < 0.0001 |
| No Angiodysplasia | Reference | Reference | Reference | |||
- Citation: Tariq T, Karabon P, Irfan FB, Goyal S, Mayeda MM, Parsons A, Judd S, Ehrinpreis M. Secondary angiodysplasia-associated gastrointestinal bleeding in end-stage renal disease: Results from the nationwide inpatient sample. World J Gastrointest Endosc 2019; 11(10): 504-514
- URL: https://www.wjgnet.com/1948-5190/full/v11/i10/504.htm
- DOI: https://dx.doi.org/10.4253/wjge.v11.i10.504